Colette Jolivet-Reynaud

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Biomerieux, Inc., Biomerieux Sa, Université François Rabelais. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Colette Jolivet-Reynaud. Retrieved from https://idiyas.com/inventor/colette-jolivet-reynaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 1)

% Patents Active = 62.5

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 47(Granted Patents)

Location History:

Bron, FR (1998 - 2011)
Saint Bonnet de Mure, FR (2009 - 2014)

Company Filing History:

Université François Rabelais

patents

4. 2 out of 1,853

National Institute of Health and Medical Research

patents

where one patent can have more than one assignee

Years Active: 1998-2014

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8716458 - NT5 and NT6 alternative transcripts of the KLK8 gene encoding kallikrein 8 (2014-05-06),

2. 8486632 - Method for the in vitro diagnosis of bronchopulmonary carcinoma by detection of major alternative transcripts of the KLK8 gene encoding kallikrein 8 and use thereof for prognosticating survival (2013-07-16),

3. 8236506 - Method for the in vitro diagnosis of bronchopulmonary carcinoma by detection of major alternative transcripts of the KLK8 gene encoding kallikrein 8 and use thereof for prognosticating survival (2012-08-07),

4. 8007792 - Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions (2011-08-30),

5. 7932350 - Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes (2011-04-26),

6. 7785586 - Monoclonal antibodies directed against hepatitis B viruses (2010-08-31),

7. 7674888 - Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes (2010-03-09),

8. 7524650 - Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions (2009-04-28),

9. 6890720 - Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis (2005-05-10),

10. 6602853 - Antigenic peptides reacting with anti-ovary antibodies (2003-08-05),

11. 6582703 - Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting (2003-06-24),

12. 6579526 - Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes (2003-06-17),

13. 6555091 - Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses (2003-04-29),

14. 6001987 - Isolated nucleotide sequences associated with Multiple sclerosis (1999-12-14),

15. 5985541 - Peptide capable of being recognized by antibodies recognizing the C33 (1999-11-16),

Title: Colette Jolivet-Reynaud: Pioneering Female Inventor from Bron, FR

Introduction: Colette Jolivet-Reynaud is a trailblazing inventor hailing from Bron, France, known for her innovative contributions to various fields.

Latest Patents: Colette Jolivet-Reynaud holds several patents in the areas of sustainable energy solutions, medical devices, and advanced materials.

Career Highlights: With a career spanning over two decades, Colette Jolivet-Reynaud has been recognized for her groundbreaking work in developing eco-friendly technologies and cutting-edge medical devices.

Collaborations: Throughout her career, Colette Jolivet-Reynaud has collaborated with leading research institutions, universities, and companies to bring her inventions to life and make a positive impact on society.

Conclusion: Colette Jolivet-Reynaud's dedication to innovation and her passion for creating solutions to real-world problems have solidified her reputation as a pioneering female inventor in the global innovation landscape.

Profile summary based on public USPTO records.